Literature DB >> 2812321

Gerstmann-Sträussler-Scheinker disease. I. Extending the clinical spectrum.

M R Farlow1, R D Yee, S R Dlouhy, P M Conneally, B Azzarelli, B Ghetti.   

Abstract

We present the clinical findings in affected members of a large kindred with Gerstmann-Sträussler-Scheinker disease. Sixty-four patients exhibited progressive ataxia, dementia, and parkinsonian features. Inheritance appears to be autosomal dominant. Impaired smooth-pursuit eye movements, defective short-term memory, clumsiness of the hands, and ataxia of gait develop in the late 30s to early 60s. Eye movement abnormalities are characteristic of cerebellar dysfunction. Dementia progresses gradually over several years. Later, rigidity and bradykinesia appear and, at this stage, there is often psychosis or severe depression with rapid weight loss. Death occurs in 6 months to 2 years after onset of rigidity. Magnetic resonance imaging in 2 affected individuals showed cerebellar atrophy. There is decreased T2 signal in the basal ganglia, consistent with iron deposition.

Entities:  

Mesh:

Year:  1989        PMID: 2812321     DOI: 10.1212/wnl.39.11.1446

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Authors:  Fumiko Furukawa; Nobuo Sanjo; Atsushi Kobayashi; Tsuyoshi Hamaguchi; Masahito Yamada; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Takanori Yokota
Journal:  Prion       Date:  2018-11-13       Impact factor: 3.931

3.  PrP amyloid plaques in Creutzfeldt-Jakob disease of short duration: immunohistochemical studies of 5 cases from Poland.

Authors:  P P Liberski; H Kwiecinski; M Barcikowska; B Mirecka; J Kulczycki; E Kida; P Brown; D C Gajdusek
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

4.  Human and experimental spongiform encephalopathies: recent progress in pathogenesis.

Authors:  M C Dal Canto
Journal:  Ital J Neurol Sci       Date:  1991-04

5.  Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.

Authors:  P Piccardo; J J Liepnieks; A William; S R Dlouhy; M R Farlow; K Young; D Nochlin; T D Bird; R R Nixon; M J Ball; C DeCarli; O Bugiani; F Tagliavini; M D Benson; B Ghetti
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 6.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

7.  [(11)C]PiB PET in Gerstmann-Sträussler-Scheinker disease.

Authors:  Kacie D Deters; Shannon L Risacher; Karmen K Yoder; Adrian L Oblak; Frederick W Unverzagt; Jill R Murrell; Francine Epperson; Eileen F Tallman; Kimberly A Quaid; Martin R Farlow; Andrew J Saykin; Bernardino Ghetti
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-01-28

8.  Creutzfeldt-Jakob disease and cerebral amyloid angiopathy.

Authors:  F Gray; F Chrétien; P Cesaro; J Chatelain; P Beaudry; J L Laplanche; J Mikol; J Bell; P Gambetti; J D Degos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP.

Authors:  Wenbin Yang; Julie Cook; Benjamin Rassbach; Azucena Lemus; Stephen J DeArmond; James A Mastrianni
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

Review 10.  Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles.

Authors:  B Ghetti; F Tagliavini; G Giaccone; O Bugiani; B Frangione; M R Farlow; S R Dlouhy
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.